Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Bln -- Update

By Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion as the Swiss...

Related Keywords

Japan ,Switzerland ,Swiss ,Vivek Ramaswamy ,Teresa Graham ,Roche Graham ,Adria Calatayud ,Roche Pharmaceuticals ,Pfizer ,Telavant Holdings ,Roche Holding ,Roivant Sciences ,Pharmaceuticals Chief Executive Teresa Graham ,Prometheus Biosciences ,Wall Street Journal ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Acquisitions Mergers ,Corporate Actions ,Corporate Industrial News ,Autoimmune Diseases ,Political General News ,Health ,Medical Conditions ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Rog Eb ,Ch Rog ,Pfe ,Roiv ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Political ,General News ,Healthcare ,Life Sciences ,